Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT06895031 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Pancreatic Ductal Adenocarcinoma (PDAC)
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)

Interventions

DRUG: JYP0015

Sponsor

Guangzhou JOYO Pharma Co., Ltd